Novasenta Inc. — Form D
Novasenta Inc. of PITTSBURGH, PA, a company, filed a Form D exempt-offering notice with the SEC on 2022-07-08. The offering totals $20.0M, of which $10.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-07-08
- Form: D
- Accession: 0001567619-22-013796
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $10.0M
- Remaining: $10.0M
- Investors: 1
- Date of first sale: 2022-06-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-451565
Issuer
- Name: Novasenta Inc.
- CIK: 0001936994
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 350 TECHNOLOGY DRIVE, PITTSBURGH, PA, 15219
- Phone: (412) 621-6200
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Moore | Director | Dallas, TX |
| Greg Delgoffe | Director | Pittsburgh, PA |
| Jeanne Cunicelli | Director | Pittsburgh, PA |
| Mani Mohindru | Director | Pittsburgh, PA |
| Mani Mohindru | Executive Officer | Pittsburgh, PA |
| Matthias Kleinz | Director | Pittsburgh, PA |
Other filings by this issuer (1)
More